Publicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (15)

2024

  1. Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

    eClinicalMedicine, Vol. 71

2023

  1. Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 8, pp. 1587-1594

  2. HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer

    Frontiers in Oncology, Vol. 13

  3. Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 587-605

2022

  1. Cuentos Lunares: Poems and Flash Fiction That Save Lives — A Euromelanoma Project During the COVID-19 Pandemic

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. 1-3

2021

  1. Cuentos Lunares: Poems and Flash Fiction That Save Lives — A Euromelanoma Project During the COVID-19 Pandemic

    Actas Dermo-Sifiliograficas

2019

  1. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion

    European Journal of Cancer, Vol. 120, pp. 54-64

  2. Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study

    Breast Cancer Research and Treatment, Vol. 177, Núm. 1, pp. 115-125

2017

  1. Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer

    Cancer Research, Vol. 77, Núm. 9, pp. 2213-2221

  2. Is mitotic rate still useful in the management of patients with thin melanoma?

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 12, pp. 2025-2029

2015

  1. Defining the dermoscopic characteristics of fast-growing cutaneous melanomas

    Melanoma Research, Vol. 25, Núm. 3, pp. 269-272

2012

  1. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2002

  1. Conferencia de Consenso sobre biopsia selectiva del ganglio centinela en el melanoma

    Clinical and Translational Oncology, Vol. 4, Núm. 7, pp. 391-396

2000

  1. Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain

    European Journal of Cancer, Vol. 36, Núm. 18, pp. 2344-2352